These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 25972559

  • 1. Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 Glycoprotein.
    Ferguson MC, Saul S, Fragkoudis R, Weisheit S, Cox J, Patabendige A, Sherwood K, Watson M, Merits A, Fazakerley JK.
    J Virol; 2015 Aug; 89(15):7536-49. PubMed ID: 25972559
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The significance of the 3'-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice.
    Santagati MG, Määttä JA, Röyttä M, Salmi AA, Hinkkanen AE.
    Virology; 1998 Mar 30; 243(1):66-77. PubMed ID: 9527916
    [Abstract] [Full Text] [Related]

  • 6. The Semliki Forest virus E2 gene as a virulence determinant.
    Santagati MG, Määttä JA, Itäranta PV, Salmi AA, Hinkkanen AE.
    J Gen Virol; 1995 Jan 30; 76 ( Pt 1)():47-52. PubMed ID: 7844541
    [Abstract] [Full Text] [Related]

  • 7. A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity.
    Glasgow GM, Killen HM, Liljeström P, Sheahan BJ, Atkins GJ.
    J Gen Virol; 1994 Mar 30; 75 ( Pt 3)():663-8. PubMed ID: 8126464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
    Glasgow GM, Sheahan BJ, Atkins GJ, Wahlberg JM, Salminen A, Liljeström P.
    Virology; 1991 Dec 30; 185(2):741-8. PubMed ID: 1660202
    [Abstract] [Full Text] [Related]

  • 13. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
    Garmashova N, Gorchakov R, Volkova E, Paessler S, Frolova E, Frolov I.
    J Virol; 2007 Mar 30; 81(5):2472-84. PubMed ID: 17108023
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pathogenesis of Semliki Forest virus encephalitis.
    Fazakerley JK.
    J Neurovirol; 2002 Dec 30; 8 Suppl 2():66-74. PubMed ID: 12491154
    [Abstract] [Full Text] [Related]

  • 19. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS.
    J Virol; 2014 Mar 30; 88(5):2385-97. PubMed ID: 24371059
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting.
    Ylösmäki E, Martikainen M, Hinkkanen A, Saksela K.
    J Virol; 2013 Jan 30; 87(1):335-44. PubMed ID: 23077310
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.